Skip to content

Construction of standardized diagnosis and treatment system and key technological innovation of temporomandibular joint-skull base-ear tumor

Construction of standardized diagnosis and treatment system and key technological innovation of temporomandibular joint-skull base-ear tumor

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036085
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular joint disease

Interventions

Group 1:Auotogenous bone graft
Group 2:Alloplastic joint replacement

Sponsors

Ninth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. aged >=18 years old; 2. with lesions of combined skull base-joint-ear defect; 3. did not participate in other clinical verification within 3 months; 4. without acute infectious disease, mental illness, systemic disease; 5. voluntary participate the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. allergy to titanium alloy plants, patients with acute or severe; 2. infection or chronic infection, patients with large soft tissue defects caused by surgery; 3. radiation osteomyelitis, acute and chronic osteomyelitis, osteoporosis; 4. complicated with heart, lung, brain, kidney and other important organs without control; 5. patients with mental illness; 6. pregnant and lactating women; 7. patients with advanced malignant tumor, distant metastasis or tumor recurrence are in critical condition, and difficult to make an accurate evaluation of the efficacy and safety of the prosthesis; 8. patients were treated with antibiotics or chronic anti-inflammatory therapy within 4 weeks before operation; 9. alcoholism or long-term drug abuse >=3 times a week); 10. uncontrollable masticatory muscle hyperfunction (night molars, clenching teeth) in patients with severe immune insufficiency leads to titanium nail overload and loosening; 11. researchers believe that patients with poor compliance can not participate in the trial; 12. in the first 30 days before the start of surgery (day 0 of the study), patients participated in clinical trials of other drugs or devices.

Design outcomes

Primary

MeasureTime frame
QOL score;Pain;Maximum mouth opening;Function;Maxillofacial morphology ;Occlusion;Lateral movement;

Countries

China

Contacts

Public ContactChi Yang

Ninth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine

yangchi63@hotmail.com+86 13818712506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026